-
Two animal models of dystonia reveal that cerebellar activity influences abnormal involuntary dystonic movements, and implicate dysfunction of a cerebellar-striatal network in the development of dystonia.
-
-
-
Platelet function testing identifies patients who do not respond to antiplatelet therapy and are at increased risk for acute stent thrombosis after neurointerventional procedures.
-
The Babinski sign continues to be a valid bed-side test for pyramidal tract lesions.
-
The anti-angiogenic monoclonal antibody, bevacizumab, shows great promise in the treatment of malignant gliomas.
-
Some women with DVT may stop warfarin after six months; Vytorin and cancer; preventing recurrent stroke; and FDA news.
-
This second publication from the COURAGE investigators reports on multiple assessments of quality of life, particularly angina presence and severity, between the two groups over the study observation.
-
Diabetic patients are at higher risk for in-stent restenosis and stent thrombosis than their non-diabetic counterparts.
-
The management of anticoagulation in patients requiring long-term warfarin therapy is often problematic when they need cardiac catheterization.
